Format

Send to

Choose Destination
Eur J Pharmacol. 1994 Aug 16;268(3):459-62.

Binding profile of the selective muscarinic receptor antagonist tripitramine.

Author information

1
Institute of Pharmacology School of Medicine, University of Pisa, Italy.

Abstract

The binding selectivity of the muscarinic antagonist tripitramine has been tested on the five cloned human muscarinic receptor subtypes (Hm1 to Hm5) expressed in chinese hamster ovary (CHO-K1) cells. The results indicate that tripitramine binds to the muscarinic Hm2 receptor with a Ki value of 0.27 +/- 0.02 nM. Tripitramine distinguishes Hm2 vs. Hm4 by a factor of 24 and vs. Hm3 and Hm5 by a factor of 142 and 125, respectively. A lower affinity ratio, about 6-fold, was found between muscarinic Hm2 and Hm1 receptors. A comparative study with the well-known selective muscarinic M2 receptor antagonist methoctramine indicates that tripitramine has gained both potency and selectivity for the muscarinic Hm2 receptor subtype.

PMID:
7805774
DOI:
10.1016/0922-4106(94)90075-2
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center